These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 24505474

  • 1. Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.
    Nygård M, Hansen BT, Dillner J, Munk C, Oddsson K, Tryggvadottir L, Hortlund M, Liaw KL, Dasbach EJ, Kjær SK.
    PLoS One; 2014; 9(2):e88323. PubMed ID: 24505474
    [Abstract] [Full Text] [Related]

  • 2. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors.
    Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM.
    Obstet Gynecol; 2009 Apr; 113(4):917-924. PubMed ID: 19305339
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Detection and Type-Distribution of Human Papillomavirus in Vulva and Vaginal Abnormal Cytology Lesions and Cancer Tissues from Thai Women.
    Ngamkham J, Boonmark K, Phansri T.
    Asian Pac J Cancer Prev; 2016 Apr; 17(3):1129-34. PubMed ID: 27039737
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States.
    Insinga RP, Liaw KL, Johnson LG, Madeleine MM.
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1611-22. PubMed ID: 18628412
    [Abstract] [Full Text] [Related]

  • 7. [AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES].
    Malinova M.
    Akush Ginekol (Sofiia); 2015 Jul; 54 Suppl 1():25-31. PubMed ID: 26137767
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cancers attributable to human papillomavirus infection.
    Grulich AE, Jin F, Conway EL, Stein AN, Hocking J.
    Sex Health; 2010 Sep; 7(3):244-52. PubMed ID: 20719211
    [Abstract] [Full Text] [Related]

  • 10. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
    FUTURE I/II Study GroupDepatment of Laboratory Medicine, Lund University, Malmö, Sweden. joakim.dillner@med.lu.se, Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Maansson R, Lu S, Vuocolo S, Hesley TM, Barr E, Haupt R.
    BMJ; 2010 Jul 20; 341():c3493. PubMed ID: 20647284
    [Abstract] [Full Text] [Related]

  • 11. Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.
    Garland SM, Joura EA, Ault KA, Bosch FX, Brown DR, Castellsagué X, Ferenczy A, Ferris DG, Giuliano AR, Hernandez-Avila M, Huh WK, Iversen OE, Kjaer SK, Kurman RJ, Luna J, Monsonego J, Muñoz N, Paavonen J, Pitisuttihum P, Ronnett BM, Steben M, Stoler MH, Wheeler CM, Wiley DJ, Perez G, Saah AJ, Luxembourg A, Li S, DiNubile MJ, Wagner M, Velicer C.
    Obstet Gynecol; 2018 Aug 20; 132(2):261-270. PubMed ID: 29995724
    [Abstract] [Full Text] [Related]

  • 12. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data.
    Joura EA, Garland SM, Paavonen J, Ferris DG, Perez G, Ault KA, Huh WK, Sings HL, James MK, Haupt RM, FUTURE I and II Study Group.
    BMJ; 2012 Mar 27; 344():e1401. PubMed ID: 22454089
    [Abstract] [Full Text] [Related]

  • 13. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
    Medeiros R, Vaz S, Rebelo T, Figueiredo-Dias M.
    Acta Med Port; 2020 Mar 02; 33(3):198-201. PubMed ID: 32130098
    [Abstract] [Full Text] [Related]

  • 14. Lower incidence of vaginal cancer after cervical human papillomavirus screening - long-term follow-up of Finnish randomized screening trial.
    Vahteristo M, Leinonen MK, Sarkeala T, Anttila A, Heinävaara S.
    Prev Med; 2024 Aug 02; 185():108031. PubMed ID: 38849059
    [Abstract] [Full Text] [Related]

  • 15. Update of HPV-associated female genital cancers in the United States, 1999-2004.
    Watson M, Saraiya M, Wu X.
    J Womens Health (Larchmt); 2009 Nov 02; 18(11):1731-8. PubMed ID: 19951205
    [Abstract] [Full Text] [Related]

  • 16. Association of human papillomavirus with vulvar and vaginal intraepithelial disease: opportunities for prevention.
    Pearson JM, Feltman RS, Twiggs LB.
    Womens Health (Lond); 2008 Mar 02; 4(2):143-50. PubMed ID: 19072516
    [Abstract] [Full Text] [Related]

  • 17. Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status.
    Mpunga T, Chantal Umulisa M, Tenet V, Rugwizangoga B, Milner DA, Munyanshongore C, Heideman DAM, Bleeker MCG, Tommasino M, Franceschi S, Baussano I, Gheit T, Sayinzoga F, Clifford GM.
    Int J Cancer; 2020 Mar 15; 146(6):1514-1522. PubMed ID: 31173641
    [Abstract] [Full Text] [Related]

  • 18. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
    Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, Copeland G, Cozen W, Peters ES, Huang Y, Saber MS, Altekruse S, Goodman MT, HPV Typing of Cancers Workgroup.
    J Natl Cancer Inst; 2015 Jun 15; 107(6):djv086. PubMed ID: 25925419
    [Abstract] [Full Text] [Related]

  • 19. The risk of vaginal, vulvar and anal precancer and cancer according to high-risk HPV status in cervical cytology samples.
    Lindquist S, Frederiksen K, Petersen LK, Kjær SK.
    Int J Cancer; 2024 Jul 01; 155(1):61-70. PubMed ID: 38418719
    [Abstract] [Full Text] [Related]

  • 20. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
    Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KE, Sings HL, James MK, Hesley TM, Barr E, Haupt RM.
    J Natl Cancer Inst; 2010 Mar 03; 102(5):325-39. PubMed ID: 20139221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.